Exhibit 99.1

                  CYTOMEDIX, INC. APPOINTS VETERAN CPA TO BOARD

          ROCKVILLE, Maryland - November 23, 2004 - Cytomedix, Inc. (OTCBB:CYME)
today announced the appointment of Arun K. Deva to its board of directors,
filling a board vacancy.

          "The addition of Arun Deva to our board represents an ongoing
commitment to attract seasoned professionals who can offer proactive counsel and
sound corporate governance. Arun's extensive financial background and accounting
experience will be invaluable to the company as we continue our growth strategy
- -- simultaneously conducting rigorous FDA-approved clinical studies for our
platelet-based therapies for chronic wound care and tissue treatment while
licensing our patents to other companies. His experiences as a partner in a
leading national accounting firm as well as his success with his own accounting
and consulting firm will assist Cytomedix in further strengthening its
compliance with the Sarbanes-Oxley and other growing requirements for public
companies," said Dr. Kshitij Mohan, chief executive officer of Cytomedix.

         Deva is the founder and president of Deva & Associates, P.C., a
Rockville, Maryland-based mid-size accounting and consulting firm, that provides
accounting, auditing, litigation support, due diligence, cost-benefit analysis,
and other financial consulting services to many Federal agencies and
corporations. He is also the founder and president of CPAMoneyWatch.com, LLC, a
web-based business services provider offering small and mid-sized businesses
with online accounting and business solutions.

         Prior to establishing Deva & Associates in 1991, Deva was a partner at
Touche Ross & Co. (now Deloitte & Touche). He has also served as a management
consultant for several public and private companies, with a focus on financial
restructurings, negotiations with lenders and creditors, financial reporting and
disclosures, and filings with the Securities and Exchange Commission. He also
was chief operating officer and chief financial officer of an emerging consumer
products company.

         Deva is a member of American Institute of Certified Public Accountants,
Maryland Association of Certified Public Accountants, and Association of
Government Accountants, and has served on professional committees. He was
appointed to the Maryland Banking Board by the Governor of Maryland for a
six-year term ending 2008.

         Deva earned his Bachelor of Commerce degree in accounting from St.
Xavier's College, India and Master of Business Administration degree in Finance
from Indiana University, Bloomington, Indiana.

About Cytomedix

         Cytomedix, Inc. is a biotechnology company specializing in processes
and products derived from autologous platelet releasates. The company owns
proprietary technology for the creation of autologous platelet gel composed of
multiple growth factors and fibrin matrix.

Additional information is available at the company's website at
www.cytomedix.com.